Trivedi, P.: "Infection of HHV-8 positive primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype and increased tumorigenicity without affecting TCL1 expression"Blood. 103. 313-316 (2004)
Trivedi, P.: "Infection of HHV-8 positive primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype and increased tumorigenicity without affecting TCL1 expression"Blood. 103. 313-316 (2004)
复制标题
Trivedi, P.：“用重组 Epstein-Barr 病毒感染 HHV-8 阳性原发性渗出性淋巴瘤细胞会导致 EBV 潜伏期受限、表型改变和致瘤性增加，而不影响 TCL1 表达”Blood。
DOI：
--
复制
发表时间：
--
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
